Nintedanib Reveals Remarkable Efficacy in Alleviating Progressive Pulmonary Fibrosis Symptoms Dr.Niharika Harsha B23 Feb 2024 6:30 PM ISTIn the groundbreaking INBUILD trial, researchers discovered that nintedanib can significantly improve the lives of patients suffering from...
Nintedanib and pirfenidone combo tied to less decline in FVC compared with monotherapy in IPF Dr. Shravani Dali1 Nov 2023 12:00 PM ISTNintedanib and pirfenidone combo well tolerated and tied to less decline in FVC compared with monotherapy in IPF suggests a new study published in the...
SSc-ILD Patients Treated with Nintedanib at high risk of weight loss and malnutrition Jacinthlyn Sylvia6 Oct 2023 9:30 AM ISTIn a recent study published in the Arthritis Care & Research found the impact of nintedanib treatment on adverse events (AEs) and the risk of...
Nintedanib Slows Lung Function Decline in Cutaneous Systemic Sclerosis Cases Jacinthlyn Sylvia29 Aug 2023 9:45 AM ISTA recent study published in the Rheumatology Journal highlight the potential of nintedanib as a treatment strategy for cutaneous systemic sclerosis...
USFDA accepts application for Boehringer Ingelheim OFEV for children, adolescents aged 6-17 years old with fibrosing interstitial lung disease Ruchika Sharma27 July 2023 1:30 PM ISTRidgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application...
Nintedanib has consistent safety profile against Systemic Sclerosis-Associated Interstitial Lung Disease Jacinthlyn Sylvia15 Jun 2023 10:00 AM ISTA new study presented at American College of Rheumatology suggests that over 148 weeks of SENSCIS-ON, the safety profile of nintedanib was consistent...
Weight loss significant among patients with idiopathic pulmonary fibrosis treated with nintedanib Medha Baranwal14 April 2023 8:00 PM ISTJapan: A recent study published in Pulmonary Pharmacology & Therapeutics has shown weight loss to be a critical issue for managing...
Nintedanib and prednisone taper combo improves pulmonary exacerbations in radiation pneumonitis Medha Baranwal12 April 2023 8:00 PM ISTUSA: Adding nintedanib to a prednisone taper improves pulmonary exacerbations in grade 2 or higher (G2+) radiation pneumonitis (RP) patients,...
Nintedanib effective and safe for elderly patients with idiopathic pulmonary fibrosis Dr.Niharika Harsha B28 March 2023 9:45 AM ISTResearchers have found in a new research that Nintedanib is effective and safe for elderly patients with idiopathic pulmonary fibrosis with clinical...
Antifibrotics improve quality of life in idiopathic pulmonary fibrosis: Study Dr. Kamal Kant Kohli28 Oct 2022 8:15 PM ISTDENMARK: In terms of enhancing survival, treatment with nintedanib and pirfenidone was preferred to no antifibrotic medication, regardless of the...
Nintedanib slows lung disease progression in systemic sclerosis over 100 weeks: SENSCIS trial Medha Baranwal26 July 2022 8:00 PM ISTUSA: Nintedanib provided a sustained benefit of slowing systemic sclerosis-associated interstitial lung disease (SSc-ILD) progression over 100 weeks...
Nintedanib found effective for drug resistant gastrointestinal stromal tumors Dr. Kamal Kant Kohli15 April 2022 7:30 PM ISTNintedanib could be used in the treatment of drug-resistant gastrointestinal stromal tumors (GISTs), finds a research led by Prof. LIU Qingsong and...
